Analyzing Rapid7 (NASDAQ:RPD) and OneMedNet (NASDAQ:ONMD)

Rapid7 (NASDAQ:RPD) and OneMedNet (NASDAQ:ONMD) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Valuation and Earnings

This table compares Rapid7 and OneMedNet”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rapid7	$859.79 million	0.47	$23.38 million	$0.36	17.00
OneMedNet	$640,000.00	49.34	-$10.13 million	($0.05)	-12.38

Rapid7 has higher revenue and earnings than OneMedNet. OneMedNet is trading at a lower price-to-earnings ratio than Rapid7, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Rapid7 has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500. Comparatively, OneMedNet has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500.

Insider & Institutional Ownership

95.7% of Rapid7 shares are held by institutional investors. Comparatively, 1.0% of OneMedNet shares are held by institutional investors. 2.4% of Rapid7 shares are held by company insiders. Comparatively, 46.2% of OneMedNet shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Rapid7 and OneMedNet’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Rapid7	2.72%	47.33%	3.01%
OneMedNet	-411.11%	N/A	-262.52%

Analyst Ratings

This is a breakdown of current ratings for Rapid7 and OneMedNet, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rapid7	3	17	2	0	1.95
OneMedNet	1	0	0	0	1.00

Rapid7 currently has a consensus price target of $12.53, suggesting a potential upside of 104.68%. Given Rapid7’s stronger consensus rating and higher probable upside, equities analysts plainly believe Rapid7 is more favorable than OneMedNet.

Summary

Rapid7 beats OneMedNet on 11 of the 14 factors compared between the two stocks.

About Rapid7

Rapid7, Inc. provides cybersecurity solutions under the Rapid7, Nexpose, and Metasploit brand names. The company offers endpoint to cloud data collection and sharing applications, such as Rapid7 Insight Agent, a software-based agent that is used on assets across on-premises and cloud environments to centralize and monitor data on company's platform; Rapid7 Insight Network Sensor that analyzes raw end-to-end network traffic to increase visibility into user activity, pinpoint real threats, and investigations; Rapid7 Cloud Event Data Harvesting that offers visibility into changes made to cloud resources; and third-party integrations and ecosystem, as well as orchestration and automation solutions. It also offers various platforms, including Rapid7 managed threat complete consisting of managed detection response that delivers end-to-end threat detection and response, as well as offloads day-to-day vulnerability management operations. In addition, it provides Rapid7 threat complete consisting of InsightIDR, a security information and event management, and extended detection and response solution; and InsightVM, a vulnerability management solution that provides visibility across on-premise and remote endpoints for security teams to evaluate the business risks, and configurations, and share with their IT counterparts for remediation. Further, the company offers Rapid7 cloud risk complete, which includes InsightCloudSec, a cloud risk and compliance management solution; and InsightAppSec, a dynamic application security testing tool. It also provides professional services. It serves a range of industries, including business services, pharmaceuticals, technology, energy, financial services, healthcare and life sciences, manufacturing, media and entertainment, retail, education, real estate, travel and transportation, government, online services, telecommunications, and professional services. The company was incorporated in 2000 and is headquartered in Boston, Massachusetts.

About OneMedNet

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.